SLC18A2 and Parkinson disease: The degeneration of the dopaminergic neurons of thesubstantia nigra pars compacta (SNc) in PD leads to the loss of nigrostriatalterminals and to the reduction of dopamine levels in the striatum.4,5 There are several evidence that link VMAT2 to dopaminergic cellloss in PD.